Annual report pursuant to Section 13 and 15(d)

Schedule of Deferred Tax Assets and Liabilities (Details)

v3.22.4
Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Tax Disclosure [Abstract]      
Share-based Compensation $ 4,512 $ 3,575  
Depreciation and Amortization (18) 166  
Accrued Liability 481 377  
Net Operating Loss Carry-forwards 21,755 24,076  
R&D Credit Carryforwards 3,773 3,207  
R&D Section 174 Costs 4,268  
Other (1) (1)  
IPR&D (851) (848)  
ROU Asset (1,027) (1,186)  
ROU Liability 1,155 1,315  
Total Deferred tax assets 34,047 30,681  
Valuation allowance (34,388) (31,023) $ (25,200)
Net deferred tax asset (liability) $ (341) $ (341)